Tamoxifen Resistant and Refractory Breast Cancer: The Value of Aromatase Inhibitors

By Goss P.E.  

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 957-966

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors

By Grubjesic Simonida   Moriarty Robert M   Pezzuto John M  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1647-1661

Informa Healthcare

Access to resources Recommend Favorite

Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer

By Miller Lesley-Ann N   Roy Anuja   Mody Reema   Higa Gerald M  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1675-1691

Informa Healthcare

Access to resources Recommend Favorite

Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors

By Lazarus Philip   Sun Dongxiao  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 182-194

Informa Healthcare

Access to resources Recommend Favorite

David Kupfer: A Career Retrospective

By Stresser David  

Drug Metabolism Reviews, Vol. 38, Iss. 1-2, 2006-05 ,pp. : 3-12

Informa Healthcare

Access to resources Recommend Favorite